Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
HALEOSLABS.NSthis companyHaleos Labs Limited	₹1,402.30	20.85×	1.69×	1.08×	10.5×	-130.3%	14.4%	8.8%	5.2%	8.1%	5.8%	-6.3%	0.52×	2.42×	4.53×	1.04×	0.1%	—	—	2	C
ALBERTDAVD.NSAlbert David Limited	₹800.90	-224.06×	0.86×	1×	25.69×	-34.8%	32.2%	-1.3%	-0.4%	-0.4%	2.8%	-10.5%	0.08×	-0.24×	-1.63×	3.24×	0.9%	2	—	2	C+
ANTHEM.NSAnthem Biosciences Ltd.	₹958.15	62.21×	12.1×	17.33×	43.89×	-76.6%	42.1%	32.9%	27.9%	19.5%	16.1%	1.9%	0.02×	-0.26×	101.5×	5.54×	0.0%	5	77.36	1	D+
BLUEJET.NSBlue Jet Healthcare Limited	₹543.55	22.9×	4.17×	5.99×	18.93×	-77.2%	43.7%	28.5%	26.2%	18.2%	14.2%	0.0%	0.03×	-0.36×	43.29×	4.21×	0.4%	3	—	2	C
DCAL.NSDishman Carbogen Amcis Limited	₹167.10	20.9×	0.3×	0.69×	7.34×	-102.0%	25.2%	7.6%	3.3%	1.5%	1.9%	3.8%	0.46×	3.71×	1.28×	1.23×	0.0%	3	—	2	C
HESTERBIO.NSHester Biosciences Limited	₹2,308.90	18.63×	2.88×	3.12×	14.18×	-111.0%	50.8%	20.4%	16.7%	15.4%	8.2%	4.0%	0.54×	2.21×	6.2×	1.37×	0.6%	4	—	3	B-
Peer median	—	20.9×	2.88×	3.12×	18.93×	-77.2%	42.1%	20.4%	16.7%	15.4%	8.2%	1.9%	0.08×	-0.24×	6.2×	3.24×	0.4%	3	77.36	2	—